GABRIELA PEREZ: Open Payments
NPI 1366095465 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 37 payments from 10 companies in 2025. Trend: 2023 $43 · 2024 $264 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 1 | $206 |
| Dexcom, Inc. | 13 | $203 |
| Insulet Corporation | 9 | $168 |
| Novo Nordisk Inc | 5 | $98 |
| Madrigal Pharmaceuticals | 2 | $52 |
| Sequel Med Tech, LLC | 2 | $39 |
| SANOFI-AVENTIS U.S. LLC | 2 | $38 |
| CeQur Corporation | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| TOLMAR, INC. | 1 | $15 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, Omnipod, REZDIFFRA, Rybelsus, Ozempic, TWIIST, TZIELD.
Industry payments across LA — which companies pay providers there.
